RBF Capital’s Trinity Biotech TRIB Stock Holding History

RBF Capital’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-99	Closed	-$25K	–	394
2019 Q2	$25K	Sell	99 -1	-1%	-$357	﹤0.01%	388
2019 Q1	$43K	Hold	100	–	–	0.01%	378
2018 Q4	$34K	Hold	100	–	–	﹤0.01%	396
2018 Q3	$60K	Hold	100	–	–	0.01%	397
2018 Q2	$75K	Hold	100	–	–	0.01%	373
2018 Q1	$77K	Hold	100	–	–	0.01%	358
2017 Q4	$77K	Hold	100	–	–	0.01%	359
2017 Q3	$84K	Hold	100	–	–	0.01%	349
2017 Q2	$90K	Hold	100	–	–	0.01%	336
2017 Q1	$89K	Hold	100	–	–	0.01%	341
2016 Q4	$104K	Hold	100	–	–	0.01%	340
2016 Q3	$198K	Hold	100	–	–	0.03%	295
2016 Q2	$170K	Hold	100	–	–	0.03%	300
2016 Q1	$175K	Hold	100	–	–	0.03%	299
2015 Q4	$176K	Hold	100	–	–	0.03%	308
2015 Q3	$172K	Hold	100	–	–	0.04%	283
2015 Q2	$271K	Hold	100	–	–	0.05%	251
2015 Q1	$289K	Hold	100	–	–	0.06%	209
2014 Q4	$263K	Hold	100	–	–	0.05%	215
2014 Q3	$274K	Hold	100	–	–	0.06%	204
2014 Q2	$345K	Hold	100	–	–	0.08%	190
2014 Q1	$363K	Hold	100	–	–	0.09%	178
2013 Q4	$377K	Hold	100	–	–	0.09%	180
2013 Q3	$326K	Hold	100	–	–	0.09%	185
2013 Q2	$253K	Buy	+100	New	+$249K	0.07%	207

Other funds holding TRIB

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ARM

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

RBF Capital's TRIB Position: Q3 2019 in Review

RBF Capital sold out of Trinity Biotech (TRIB) in Q3 2019, closing a stake of 99 shares — an estimated $25K sold.

RBF Capital first reported a position in TRIB in Q2 2013 and held it in 25 quarters. The position peaked at $377K in Q4 2013. 28 funds tracked by Wall St. Rank hold TRIB as of Q3 2019.

RBF Capital reported no remaining Trinity Biotech position as of Q3 2019 after selling out during the quarter.
RBF Capital sold 99 Trinity Biotech shares in Q3 2019, an estimated $25K.
RBF Capital first reported a position in Trinity Biotech in Q2 2013 and held it in 25 quarters.
RBF Capital's Trinity Biotech position peaked at $377K in Q4 2013.
28 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2019.

Based on RBF Capital's 13F filing for Q3 2019, filed 13 Nov 2019.